Wenting Sun

ORCID: 0000-0002-8723-2191 · 6 papers in corpus
rct 2023
JAMA network open ·doi:10.1001/jamanetworkopen.2023.17860

IMPORTANCE: Adenomyosis is a common chronic gynecological disorder, and its treatment is an unmet need. New therapies need to be developed. Mifepristone is being tested for adenomyosis treatment. OBJECTIVE: To determine whether mifepriston…

observational 2022
·doi:10.1097/rd9.0000000000000031

Objective: To study the 12-month effects and possible mechanisms of low-dose mifepristone in the treatment of adenomyosis. Methods: Patients included in this retrospective study had painful adenomyosis and previously received 5 mg mifeprist…

2021
·doi:10.2139/ssrn.3897694
observational 2021
Medicine ·doi:10.1097/md.0000000000026753

Triptorelin has been used after surgery in deep infiltrating endometriosis. This post-hoc analysis aimed to evaluate symptom control between patients receiving 1-3 triptorelin injections and those receiving 4-6 injections within 24 months o…

observational 2020
Annals of translational medicine ·doi:10.21037/atm-20-3420

BACKGROUND: Although the levonorgestrel-releasing intrauterine device (LNG-IUD) has been widely applied in the treatment of adenomyosis, not all the patients are satisfied with its efficacy. The present retrospective study aimed to investig…

nonrandomized-trial 2019
Journal of cellular and molecular medicine ·doi:10.1111/jcmm.14866

Adenomyosis is also called internal endometriosis and affects about 20% of reproductive-aged women. It seriously reduces life quality of patients because current drug therapies face with numerous challenges. Long-term clinical application o…